Colorado-based Cerapedics closes $9 million in venture debt financing from GE Capital’s Health Financial Services in support of the i-FACTOR Peptide Enhanced Bone Graft. Tech and healthcare giant GE (NYSE:GE) put some skin in Cerapedics and its i-FACTOR bone graft, funding a $9 million venture debt financing round for the Colorado-based company. Cerapedics plans to use the funds to make progress toward the U.S market and to support “general business operations,” the company said this month.
Help employers find you! Check out all the jobs and post your resume.
